The results of this study provide further clinical evidence that patient-applied, patch-based PSG is a viable alternative to in-lab PSG, enabling broader access to gold-standard sleep testing.

An announcement from Blinklab Limited ( ($AU:BB1) ) is now available. BlinkLab has secured a significant validation of its technology with the ...